fbpx
Genome Testing - Texas Integrative Medicine
2118
page-template-default,page,page-id-2118,ajax_fade,page_not_loaded,,select-theme-ver-1.5,wpb-js-composer js-comp-ver-5.4.5,vc_responsive

Texas Integrative Medicine Genome Testing

Chronic inflammation-based disease states like chronic fatigue, autoimmune disease, and chronic mood and cognitive disorders are typically seen in individuals who have an increased susceptibility to develop chronic illness which has a genetic root cause.  Nowadays, thanks to recent genetic discovery, the nature of the increased susceptibility is able to be better understood and often steps can be taken to lessen this increased likelihood to be chronically ill.  Many people are aware of the role of the MTHFR gene in chronic disease.  This is just one of many important gene variants (SNPs) that provide clues of chronic disease predisposition.

Initial Evaluation

When our initial evaluation of the patient indicates that knowledge of genetic predisposition is sufficiently likely to assist in chronic disease management, we recommend genetic variant testing.  Although this is not necessary in every case, it is frequently recommended in our patient assessments.

Salivary genome analysis with the Your Gene Resource saliva test available from Functional Genomic Analysis provides a very good date set of gene information that when appropriately interpreted can provide actionable information that may contribute to improvement of many chronic disease states. The sample for this test can be obtained in our office and your extensive genetic test report is available for our providers to interpret just a few weeks later.

We stock genetic test kits for ease and convenience

Texas Integrative Medicine is partnered with Functional Genomic Analysis to offer the Your Gene Resource genome analysis test providing gene testing from our office. The genetic information provided in the report provides clinically relevant information for the determination of recommendations for interventions to help alleviate the adverse effects of the gene variants contributing to inflammation, disorders of detoxification and chronic disease

The patient’s inherited status (wild-type, heterozygous, or homozygous) for 19, 922 gene variants of 1,339 important protein-coding genes including MTHFR, SOD, CBS, MTR, NOS, MAO, COMT, ACAT, SHMT, CYP, PON, FUT, BHMT, MAT, and a number of others is determined.  The testing along with a copy of the report is provided to each patient.  Explanation of the report’s information by the doctor is critical to proper implementation of the findings.